Innate immune responses in oral mucosa

Abstract

It is speculated that more than 400 bacterial species reside in the oral cavity. Some cause inflammation (e.g. periodontitis), understanding of which requires examination of innate immunity in the oral cavity. Oral mucosal cells such as epithelial cells are thought to act as a physical barrier against the invasion of pathogenic organisms, but they have an ability to produce inflammatory cytokines and express adhesion molecules. Oral epithelial cells are refractory to many bacterial components although they express Toll-like receptors/MyD88, and acquire responsiveness after priming with IFN- . When the cells are stimulated with lipopolysaccharide (LPS) and neutrophil protease (PR3) after IFN- priming, the cells produce bio-active IL-18, which is critical to Th1 and Th2 responses. PR3 itself is able to activate the cells through G protein-coupled protease-activated receptor-2 on the cell surface. These results suggest that innate immune responses of oral epithelial cells to bacterial components are regulated in the inflammatory process. In addition, saliva contains abundant bio-active CD14 from salivary glands in a soluble form, although LPS-binding protein was below detectable levels, suggesting that saliva CD14 is important for the maintenance of oral health.

References

Lundqvist C. , Baranov V. , Teglund S. , Hammarström S. , Hammarström M-L. Cytokine profile and ultrastructure of intraepithelial T cells in chronically inflamed human gingiva suggest a cytotoxic effector function. J Immunol 1994; 153: 2302—2312.

Huang Gt-J , Haake SK , Kim J-W. , Park N-H. Differential expression of interleukin-8 and intercellular adhesion molecule-1 by human gingival epithelial cells in response to Actinobacillus actinomycetemcomitans or Porphyromonas gingivalis infection. Oral Microbiol Immunol 1998; 13: 301—309.

Sugiyama A. , Uehara A. , Iki K. et al. Activation of human gingival epithelial cells by cell-surface components of black-pigmented bacteria: augmentation of production of interleukin-8, granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor and expression of intercellular adhesion molecule 1. J Med Microbiol 2002; 51: 27—33.

Mandel ID The functions of saliva. J Dent Res 1987; 66: 623—627.

Tenovuo J. , Gråhn E. , Lehtonen O-P. , Hyyppä T. , Karhuvaara L. , Vilja P. Antimicrobial factors in saliva: ontogeny and relation to oral health . J Dent Res 1987; 66: 475—479.

Uehara A. , Sugawara S. , Tamai R. , Takada H. Contrasting responses of human gingival and colonic epithelial cells to lipopolysaccharide, lipoteichoic acids and peptidoglycans in the presence of soluble CD14. Med Microbiol Immunol 2001 ; 189: 185—192.

Sugiyama A. , Arakaki R. , Ohnishi T. , Arakaki N. , Daikuhara Y. , Takada H. Lipoteichoic acid and interleukin 1 stimulate synergistically production of hepatocyte growth factor (scatter factor) in human gingival fibroblasts in culture. Infect Immun 1996; 64: 1426—1431.

Sugawara S. , Nemoto E. , Tada H. , Miyake K. , Imamura T. , Takada H. Proteolysis of human monocyte CD14 by cysteine proteinases (gingipains) from Porphyromonas gingivalis leading to lipopolysaccharide hyporesponsiveness . J Immunol 2000; 165: 411—418.

Uehara A. , Sugawara S. , Takada H. Priming of human oral epithelial cells by interferon- to secrete cytokines in response to lipopolysaccharides, lipoteichoic acids and peptidoglycans . J Med Microbiol 2002; 51: 626—634.

10.

Sugawara S. , Uehara A. , Nochi T. et al. Neutrophil proteinase 3-mediated induction of bioactive IL-18 secretion by human oral epithelial cells. J Immunol 2001; 167: 6568—6575.

11.

Uehara A. , Sugawara S. , Muramoto K. , Takada H. Activation of human oral epithelial cells by neutrophil proteinase 3 through protease-activated receptor-2. J Immunol 2002 ; 169: 4594—4603.

12.

Okamura H. , Tsutsui H. , Komatsu T. et al. Cloning of a new cytokine that induces IFN- by T cells. Nature 1995; 378: 88—91.

13.

Nakanishi K. , Yoshimoto T. , Tsutsui H. , Okamura H. Interleukin-18 regulates both Th1 and Th2 responses. Annu Rev Immunol 2001; 19: 423—474.

14.

Kitchens RL , ThompsonPA, Viriyakosol S, O'Keefe GE, Munford RS. Plasma CD14 decreases monocyte responses to LPS by transferring cell-bound LPS to plasma lipoproteins. J Clin Invest 2001; 108: 485—493.